RISPERDAL RECENT NEWS FREE

RISPERDAL RECENT NEWS FREE

Get your free Risperdal claim review today and an attorney will contact you to discuss your case. More men are filing Risperdal lawsuits, and now’s the time to get the damages you deserve. The court dismissed Johnson & Johnson’s appeal of a 2019 ruling by the Superior Court of Pennsylvania that upheld the verdict in favour of a man from Tennessee who had been prescribed Risperdal in 2003 when he was just four years old. It’s a good idea to speak with an attorney before filing your Risperdal claim. In May this year, the US Supreme Court rejected a bid by the company to overturn a $70 million jury verdict against it for failing to warn consumers about the risks associated with off-label uses of Risperdal. In 2013, Johnson & Johnson separately agreed to pay $2.2 billion to settle US criminal and civil probes into its marketing of the drug as well as two others. In 2006, the drug was also approved to help treat irritability associated with autism in children. Risperdal was approved by the US Food and Drug Administration in 1993 to help treat bipolar mania and schizophrenia in adults. Get the latest news and updates from Rainwater, Holt & Sexton. the first group of the recent Risperdal trials will begin in June 2019. However, Johnson & Johnson denied the claims. If you or your child took Risperdal before its FDA pediatric approvals in 2007 and. Risperdal lawsuits have been filed after the drug caused abnormal breast tissue.

The lawsuits generally accused Johnson & Johnson of failing to warn consumers of the risk of gynecomastia, a condition associated with Risperdal, which they say Johnson & Johnson marketed for off-label, unapproved uses with children. On Friday, Johnson & Johnson said in a filing with the US Securities and Exchange Commission that it had reached a settlement to resolve all of the roughly 9,000 cases that it faced over its anti-psychotic drug Risperdal.

Risperdal recent news